Nuzenio

Celldex Therapeutics

Celldex Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 21:15:24 GMTWhat Is Celldex Therapeutics (CLDX) Signaling With Its Mixed Pipeline Update? - Yahoo Finance
Sat, 08 Aug 2026 08:41:01 GMTFirst Trust Advisors LP Has $2.17 Million Stock Holdings in Celldex Therapeutics, Inc. $CLDX - MarketBeat
Sat, 08 Aug 2026 04:52:38 GMTCelldex Therapeutics (NASDAQ:CLDX) Issues Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Fri, 07 Aug 2026 19:21:23 GMTMorgan Stanley Boosts Celldex Therapeutics (NASDAQ:CLDX) Price Target to $46.00 - MarketBeat
Fri, 07 Aug 2026 09:14:13 GMTCLDX SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocus
Thu, 06 Aug 2026 23:10:20 GMTCelldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Celldex Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.